Immediate Impact
34 standout
Citing Papers
Long-term safety, tolerability, and efficacy of efgartigimod (ADAPT+): interim results from a phase 3 open-label extension study in participants with generalized myasthenia gravis
2024 Standout
Myasthenia gravis: the changing treatment landscape in the era of molecular therapies
2024 Standout
Works of Laura O’Connor being referenced
Myasthenia Gravis and Physical Exercise: A Novel Paradigm
2020
Pattern of Habitual Physical Exercise in Myasthenia Gravis Patients
2018
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Laura O’Connor | 69 | 60 | 22 | 59 | 22 | 227 | |
| Karl C. Alcover | 27 | 40 | 23 | 49 | 32 | 210 | |
| Megan Williamson | 34 | 45 | 13 | 82 | 17 | 245 | |
| Eric Riklin | 20 | 118 | 22 | 22 | 15 | 290 | |
| Melissa Gates | 28 | 110 | 6 | 38 | 19 | 268 | |
| Vy Pham | 45 | 85 | 17 | 11 | 20 | 249 | |
| Lívia Gaspar Fernandes | 72 | 20 | 9 | 90 | 17 | 206 | |
| Siobhán O’Higgins | 80 | 45 | 24 | 45 | 25 | 253 | |
| Julie Teater | 23 | 50 | 10 | 102 | 20 | 239 | |
| Mapi Fleury | 19 | 36 | 19 | 31 | 18 | 224 | |
| Madison E. Stout | 46 | 90 | 16 | 59 | 26 | 296 |
All Works
Login with ORCID to disown or claim papers
Loading papers...